This matters more than people realize.Semaglutide, tirzepatide, liraglutide off the 503B list = compounding pharmacies can't touch the biggest GLP-1s. Patients go through brand-name channels or nothing.Meanwhile the July 23-24 PCAC meeting will decide on 10 other peptides for reclassification.The peptide access landscape is splitting in two: corporate-controlled GLP-1s and everything else. We're tracking all of it.
0:10
This matters more than people realize.Semaglutide, tirzepatide, liraglutide off the 503B list = compounding pharmacies can't touch the biggest GLP-1s. Patients go through brand-name channels or nothing.Meanwhile the July 23-24 PCAC meeting will decide on 10 other peptides for reclassification.The peptide access landscape is splitting in two: corporate-controlled GLP-1s and everything else. We're tracking all of it.
104.3K views2 months ago
x.comThePeptideList
See more
Static thumbnail place holder